SEC Form 4 · accession 0001192482-18-000260
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Ciaffoni
Officer — Chief Operating Officer
Period of report
May 31, 2018
Accepted (ET)
Jun 4, 2018 · 6:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 31, 2018 | M | 64,821 | $8.22 | A | 174,089 | D | |
| Common StockF2 | May 31, 2018 | S | 59,204 | $22.54 | D | 114,885 | D | |
| Common StockF3 | May 31, 2018 | S | 5,617 | $23.35 | D | 109,268 | D | |
| Common StockF4 | May 31, 2018 | F | 6,205 | $22.62 | D | 103,063 | D | |
| Common StockF5 | Jun 1, 2018 | S | 14,862 | $22.48 | D | 88,201 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to purchase)F6 | $8.22 | May 31, 2018 | M | 64,821 | D | — | May 31, 2027 | Common Stock | 64,821 | 194,462 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2017.
- F2The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.10 to $23.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (5).
- F3The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.10 to $23.45, inclusive.
- F4Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
- F5The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.14 to $22.91, inclusive.
- F664,821 shares subject to the option vested and became exercisable on May 31, 2018. The remaining 194,462 shares subject to the option vest in equal quarterly installments (rounded up to the nearest whole share of common stock) over a three year period, subject to the reporting person's continued service with the issuer.